Article Archives

Sort

An interview with Gianmarco Negrisoli, President, Flamma USA
Monday, April 22, 2024

The continued consolidation of CDMOs into larger conglomerates is definitely bringing new dynamics to the outsourcing market. The onestop-shop is a ... read more
Advanced Supply Chain Visibility Technologies to Save Money and Ensure Quality Products
Thursday, February 01, 2024

Supply chain visibility has garnered additional importance and scrutiny with the advent and increase in the number and complexity of next-generation ... read more
Engineering, Validation, Automation and Service Companies in the Pharmaceutical Manufacturing Ecosystem
Thursday, February 01, 2024

The COVID-19 crisis has emphasized the need for a pharmaceutical industry capable of developing new products to respond to public health emergencies, ... read more
Enabling Quality and On-Time Tech Transfer of a Drug Product
Thursday, February 01, 2024

Demand is growing for more rapid drug development and commercialization timelines. Expediting development and manufacturing time frames allows drug ... read more
Using Tech-Enabled Solutions to Boost Productivity and Sustainability in Clinical Trials
Thursday, February 01, 2024

Clinical trials are expanding rapidly, with government statistics listing 472,608 studies currently taking place across 222 countries. In this ... read more
Faithful Migration: Best Practices for Moving from Paper-Based Patient Reported Outcomes to Advanced Digital Platforms
Thursday, February 01, 2024

Clinical research has evolved significantly with the use of patient-centric technology, and the move from paper-based patient-reported outcomes (PROs)... read more
An Interview With Amanda Blackwell - Head of Analytical Development, PCI Pharma Services Tredegar.
Thursday, February 01, 2024

Analytical method development is a cornerstone of pharmaceutical outsourcing. In this Q&A, Amanda Blackwell—Head of Analytical Development at PCI ... read more
Time to Move Out of Our Comfort Zone and Embrace New Approaches to Clinical Trial Payment
Thursday, February 01, 2024

With the clinical research sector striving to ensure the products it develops are suited to all the people who rely on them, no matter what their ... read more
An Interview With Adam Sherlock – CEO, Rephine
Thursday, February 01, 2024

The Third-Party Audit Report Library (3PARL®) consortium was established to set global benchmarks for life sciences manufacturing supply chain GMP ... read more
Why eConsent is a Win-Win for Patients, Clinical Trial Sponsors and Staff
Thursday, February 01, 2024

While electronic informed consent (eConsent) has been increasingly leveraged across clinical trials due to its many proven benefits, some trial ... read more
The Achilles Heel of Emerging and Mid-Market Biopharma Companies: Costly Clinical Trial Delays
Thursday, February 01, 2024

In the fast-paced world of biopharmaceuticals, emerging and mid-market companies face significant challenges when bringing innovative drugs to market.... read more
How a New Rapid EMSA Method is Impacting Plasma Protein Binding in Oligonucleotides
Thursday, February 01, 2024

Drug development is a rapidly evolving field in which precision and efficiency in analysis methods are paramount. And understanding plasma protein ... read more
A Quarterly Review of New Drug Applications – October-December 2023
Thursday, February 01, 2024

This quarterly review on New Drug Applications contains data for applications approved during the fourth quarter of 2023, which includes New Molecular... read more
Big Opportunities Remain in Small Molecule Innovation
Wednesday, November 01, 2023

By its nature, the pharmaceutical industry thrives on innovation and the quest to find new ways to tackle diseases, and the response to the COVID ... read more
How Can Novel Antibiotics Help Combat Antimicrobial Resistance?
Wednesday, November 01, 2023

In the last 100 years, antibiotics have drastically changed modern medicine, helping to drive a phenomenal decrease in mortality rates due to ... read more

Sort

An interview with Gianmarco Negrisoli, President, Flamma USA

Advanced Supply Chain Visibility Technologies to Save Money and Ensure Quality Products

Engineering, Validation, Automation and Service Companies in the Pharmaceutical Manufacturing Ecosystem

Enabling Quality and On-Time Tech Transfer of a Drug Product

Using Tech-Enabled Solutions to Boost Productivity and Sustainability in Clinical Trials

Faithful Migration: Best Practices for Moving from Paper-Based Patient Reported Outcomes to Advanced Digital Platforms

An Interview With Amanda Blackwell - Head of Analytical Development, PCI Pharma Services Tredegar.

Time to Move Out of Our Comfort Zone and Embrace New Approaches to Clinical Trial Payment

An Interview With Adam Sherlock – CEO, Rephine

Why eConsent is a Win-Win for Patients, Clinical Trial Sponsors and Staff

The Achilles Heel of Emerging and Mid-Market Biopharma Companies: Costly Clinical Trial Delays

How a New Rapid EMSA Method is Impacting Plasma Protein Binding in Oligonucleotides

A Quarterly Review of New Drug Applications – October-December 2023

Big Opportunities Remain in Small Molecule Innovation

How Can Novel Antibiotics Help Combat Antimicrobial Resistance?

2024 Contract Services Directory and Guide

2024 Contract Services Directory and Guide

Subscriptions

Connect with Us

Sign up for our eNewsletter!